Hyderabad: Dr. Reddy's Laboratories has launched sildenafil tablets (20 mg), a bioequivalent generic version of Revatio tablets in the US market.

Revatio is indicated for the treatment of pulmonary arterial hypertension (PAH) in order to improve exercise ability, help lessen symptoms, and slow down worsening changes in patients physical condition. Sildenafil is the same drug that is also found in Viagra, which is used for the treatment of erectile dysfunction (impotence). 

The launch took place after the US FDA approved Dr. Reddy's Abbreviated New Drug Application (ANDA) for Sildenafil tablets. The Revatio brand reported sales of approximately $338.67 million in US alone for the 12 months ending September 2012, according to IMS Health. Dr. Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes.